GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Days Sales Outstanding

OraSure Technologies (FRA:EP3) Days Sales Outstanding : 62.44 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies Days Sales Outstanding?

OraSure Technologies's average Accounts Receivable for the three months ended in Mar. 2024 was €34.1 Mil. OraSure Technologies's Revenue for the three months ended in Mar. 2024 was €49.8 Mil. Hence, OraSure Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 62.44.

The historical rank and industry rank for OraSure Technologies's Days Sales Outstanding or its related term are showing as below:

FRA:EP3' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.87   Med: 60.69   Max: 84.74
Current: 68.97

During the past 13 years, OraSure Technologies's highest Days Sales Outstanding was 84.74. The lowest was 49.87. And the median was 60.69.

FRA:EP3's Days Sales Outstanding is ranked worse than
55.54% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 65.015 vs FRA:EP3: 68.97

OraSure Technologies's Days Sales Outstanding increased from Mar. 2023 (52.70) to Mar. 2024 (62.44).


OraSure Technologies Days Sales Outstanding Historical Data

The historical data trend for OraSure Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Days Sales Outstanding Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.78 84.27 63.57 53.36 50.88

OraSure Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.70 86.23 53.90 56.96 62.44

Competitive Comparison of OraSure Technologies's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, OraSure Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's Days Sales Outstanding falls into.



OraSure Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

OraSure Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (66.832 + 36.837) / 2 ) / 371.818*365
=51.8345 / 371.818*365
=50.88

OraSure Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (36.837 + 31.314) / 2 ) / 49.801*365 / 4
=34.0755 / 49.801*365 / 4
=62.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies  (FRA:EP3) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


OraSure Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines